Literature DB >> 21779435

Tyrosine Kinase Receptor Flt/VEGFR Family: Its Characterization Related to Angiogenesis and Cancer.

Masabumi Shibuya1.   

Abstract

Ligands and their tyrosine kinase (TK) receptors regulate a variety of biological systems in animals. Vascular endothelial growth factor (VEGF) and its receptor (Flt/VEGFR family) system play a crucial role not only in physiological but also in most parts of pathological angiogenesis including cancer. Flt-1/VEGFR-1 and KDR/VEGFR-2 bind VEGF-A but have different functions on angiogenesis at early embryogenesis: Flt-1 has a negative role by trapping ligands, whereas KDR (Flk1 in mice) exerts a strong positive signal, resulting in a balance in blood vessel formation. At adult stages, however, both VEGFRs contribute to pathological angiogenesis either directly or through stimulation of migration/activation of macrophage lineage cells and stimulate tumor growth, metastasis, and inflammation. VEGFRs activate downstream signaling of the phospholipase Cγ-protein kinase C-MAP kinase pathway but not Ras pathway for cell proliferation. The VEGF-C/D and Flt-4/VEGFR-3 system regulates lymphangiogenesis. Thus, VEGFs as well as these receptor TKs are attractive targets for suppressing pathological angiogenesis.

Entities:  

Keywords:  phospholipase C; tumor angiogenesis; tyrosine kinase receptor; vascular endothelial growth factor

Year:  2010        PMID: 21779435      PMCID: PMC3092272          DOI: 10.1177/1947601910392987

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  40 in total

Review 1.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

2.  Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages.

Authors:  Masato Murakami; Shinobu Iwai; Sachie Hiratsuka; Mai Yamauchi; Kazuhide Nakamura; Yoichiro Iwakura; Masabumi Shibuya
Journal:  Blood       Date:  2006-05-18       Impact factor: 22.113

3.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Authors:  G H Fong; J Rossant; M Gertsenstein; M L Breitman
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

5.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

6.  Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Authors:  A Sawano; T Takahashi; S Yamaguchi; M Aonuma; M Shibuya
Journal:  Cell Growth Differ       Date:  1996-02

7.  Flt-1 signaling in macrophages promotes glioma growth in vivo.

Authors:  Mark Kerber; Yvonne Reiss; Anke Wickersheim; Manfred Jugold; Fabian Kiessling; Matthias Heil; Vadim Tchaikovski; Johannes Waltenberger; Masabumi Shibuya; Karl H Plate; Marcia Regina Machein
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

8.  Hypoxia and low-nutrition double stress induces aggressiveness in a murine model of melanoma.

Authors:  Tsuyoshi Osawa; Masashi Muramatsu; Makoto Watanabe; Masabumi Shibuya
Journal:  Cancer Sci       Date:  2009-02-10       Impact factor: 6.716

Review 9.  Molecular mechanisms of lymphangiogenesis in health and disease.

Authors:  Kari Alitalo; Peter Carmeliet
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

10.  The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.

Authors:  A Kaipainen; J Korhonen; K Pajusola; O Aprelikova; M G Persico; B I Terman; K Alitalo
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Overcoming resistance to antiangiogenic therapies.

Authors:  Sabine Tejpar; Hans Prenen; Massimiliano Mazzone
Journal:  Oncologist       Date:  2012-07-06

2.  Cloning and expression of soluble vascular endothelial growth factors receptor-1 (sFlt-1) fragments in CHO-K1.

Authors:  Poopak Farnia; Mojgan Bandehpour; Jalaledin Ghanavi; Bahram Kazemi
Journal:  Int J Clin Exp Med       Date:  2013-09-25

3.  Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Esther M John; Gabriela Torres-Mejia; Abbie Lundgreen; Juan Pablo Lewinger; Mariana C Stern; Lisa Hines; Kathy B Baumgartner; Anna R Giuliano; Roger K Wolff
Journal:  Int J Cancer       Date:  2013-08-09       Impact factor: 7.396

Review 4.  Killer Timing: The Temporal Uterine Natural Killer Cell Differentiation Pathway and Implications for Female Reproductive Health.

Authors:  Rupsha Fraser; Ana Claudia Zenclussen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-27       Impact factor: 6.055

Review 5.  Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept.

Authors:  Guido Giordano; Antonio Febbraro; Michele Venditti; Serena Campidoglio; Nunzio Olivieri; Katia Raieta; Pietro Parcesepe; Giusy Carmen Imbriani; Andrea Remo; Massimo Pancione
Journal:  Gastroenterol Res Pract       Date:  2014-07-21       Impact factor: 2.260

6.  Effects of tetrahydrocurcumin on hypoxia-inducible factor-1α and vascular endothelial growth factor expression in cervical cancer cell-induced angiogenesis in nude mice.

Authors:  Bhornprom Yoysungnoen; Parvapan Bhattarakosol; Suthiluk Patumraj; Chatchawan Changtam
Journal:  Biomed Res Int       Date:  2015-02-18       Impact factor: 3.411

7.  Ubiquitination of basal VEGFR2 regulates signal transduction and endothelial function.

Authors:  Gina A Smith; Gareth W Fearnley; Izma Abdul-Zani; Stephen B Wheatcroft; Darren C Tomlinson; Michael A Harrison; Sreenivasan Ponnambalam
Journal:  Biol Open       Date:  2017-10-15       Impact factor: 2.422

8.  Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer.

Authors:  M Nishio; T Horai; A Horiike; H Nokihara; N Yamamoto; T Takahashi; H Murakami; N Yamamoto; F Koizumi; K Nishio; W Yusa; N Koyama; T Tamura
Journal:  Br J Cancer       Date:  2013-07-16       Impact factor: 7.640

9.  TGF-β1 induces the formation of vascular-like structures in embryoid bodies derived from human embryonic stem cells.

Authors:  Yan Wang; DE-Jian Qian; Wen-Yu Zhong; Jun-Hong Lu; Xiang-Kai Guo; Yi-Lin Cao; Ju Liu
Journal:  Exp Ther Med       Date:  2014-05-19       Impact factor: 2.447

10.  VEGFR2 Trafficking, Signaling and Proteolysis is Regulated by the Ubiquitin Isopeptidase USP8.

Authors:  Gina A Smith; Gareth W Fearnley; Izma Abdul-Zani; Stephen B Wheatcroft; Darren C Tomlinson; Michael A Harrison; Sreenivasan Ponnambalam
Journal:  Traffic       Date:  2015-12-02       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.